Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

SSL International

SSL International plc is a manufacturer and distributor of healthcare products sold into consumer markets worldwide. SSL has a diverse portfolio of consumer products which include Durex and Scholl

The company in detail

Profile

SSL International plc is a manufacturer and distributor of healthcare products sold into consumer markets worldwide. SSL has a diverse portfolio of consumer products which include the global brands, Durex* condoms and personal lubricants, Scholl* footcare and footwear as well as local over-the-counter brands such as Syndol, Meltus and Full Marks in the UK and Sauber, Mister Baby and Proxima Baby in Southern Europe (*See separate profiles for Durex & Scholl) SSL employs around 5,000 people operating from commercial offices in over 35 countries and has manufacturing capabilities in Thailand, Spain and the UK as well as joint venture manufacturing in India and China. The head office is in London. In March 2003, SSL announced a strategy to divest its medical division; this disposal programme has now been completed, and for the first time since its creation, SSL is now uniquely positioned to focus on its consumer brands free of distractions. The aim is to exploit the considerable potential of these brand assets and three objectives have been set to achieve this: To grow 'brand contribution' by driving sales growth and creating brand value through investment in effective advertising and continual development of new products, through innovation, which are aligned to customer needs. To re-energise and invigorate staff, following the period of change and continue to employ highly motivated, well remunerated and success oriented people throughout the organisation. Challenge the cost base throughout the organisation without jeopardising the goal of brand growth. In short, the strategy is to build brands and grow sales, develop new products and cut costs to meet and beat industry standards with the objective of growing value for SSL shareholders.

Partnering strategy/interests

Partnering Strategy Along with internal innovation and development programs, external collaborations form a major part of SSL's R&D strategy SSL are interested in establishing partnerships and licensing agreements with external companies in order to bring products in mid/late stages of development to market. SSL is also actively looking for fully developed products that it could in-license for the UK and Irish OTC markets to complement their current portfolio. Partnerships SSL has marketing and distribution agreements with Wilkinson Sword in Australia, Schering Plough (Coppertone) in Japan, Comasec (Marigold Household Gloves) in Europe and Cadbury's Schweppes (V6 dental gum) in Spain.

In-licensing

Seeking opportunities for OTC consumer healthcare products in the area of Children's Medicines. More
Seeking opportunities for OTC consumer healthcare products. More
Seeking opportunities for OTC consumer healthcare products in the area of cough & cold products. More
Seeking opportunities for OTC consumer healthcare products in the area of oral and topical pain relief products. More

R&D

To view this information, you must subscribe to Partneringtools.

Partnerships

To view this information, you must subscribe to Partneringtools.

Deals

To view this information, you must subscribe to Partneringtools.

Senior management

To view this information, you must subscribe to Partneringtools.

Board of directors

To view this information, you must subscribe to Partneringtools.

Head office

SSL International
Venus Building
1 Old Park Lane
Trafford Park
Manchester
Lancashire
M14 7HA
United Kingdom

Tel:  +44 161 638 2282
Fax: +44 161 621 2094
www | email

Contact details

Ms Paula Lashley
Category Information Analyst
Knowledge Management
Request more information

Company figures

Formed: 1999
Annual Turnover: 408million
Number of employees: 4500

Related categories

Industry sector
Drug delivery / Oral solid
Drug delivery / Topical
Drug delivery / Oral liquid
Drug delivery / Vaginal
Drug delivery / Nasal
Medical device / Therapeutic device
Pharmaceutical / OTC/Non-Prescription
Pharmaceutical / Personal Care
Therapeutic target
Accident and Trauma / Muscle sprain/strain
Central Nervous System / CNS (other) / Sexual dysfunction
Central Nervous System / Neurological / Migraine
Central Nervous System / Pain / Pain management general
Central Nervous System / Pain / Pain, acute
Dermatological / Insect bite
Dermatological / Fungal infection
Dermatological / Skin infection (other)
Dermatological / Burns
Gastrointestinal / Diarrhea
Gastrointestinal / Emesis, motion
Gastrointestinal / Flatulence
Gastrointestinal / Dyspepsia
Gastrointestinal / Electrolyte replacement
Genito-urinary / Gender related medicine female / Contraception, female
Genito-urinary / Sexually transmitted diseases / Sexually transmitted diseases (other)
Genito-urinary / Gender related medicine male / Contraception, male
Genito-urinary / Genito-urinary other / Reproductive health (other)
Infectious diseases / Diseases / Warts
Infectious diseases / Diseases / Infection, fungal (other)
Infectious diseases / Diseases / Fever
Infectious diseases / Diseases / Rhinovirus (common cold)
Musculoskeletal / Musculoskeletal disorder (other)
Musculoskeletal / Back pain
Musculoskeletal / Skeletal / Rheumatoid arthritis
Musculoskeletal / Skeletal / Arthritis (non-specific)
Musculoskeletal / Skeletal / Osteoarthritis
Oral Health / Aphthous ulcers
Infectious diseases / Parasitic diseases / Infection, parasitic
Respiratory / Rhinovirus (common cold)
Respiratory / Cough
Respiratory / Rhinitis
Sensory organ / Auditory / Ear disorder (other)
Small trial ad
MipTec
Yissum Technology Transfer Hebrew University
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us